Oct 6, 2025 | Independent pharmacies, Legislative, Pharmacy, Pharmacy Benefits Manager (PBM), Prescription, State legislation
Independent pharmacies across the country are facing financial strain, with many closing their doors due to unsustainable reimbursement rates and restrictive practices imposed by the major pharmacy benefit managers (PBMs). In response, states are taking legislative...
Sep 23, 2025 | Brian Fargus, Brooke Hupp, Cancer, Conferences, Cost Savings, Drug costs, Health care costs, Innovations, Pharmacy, Prescription, Rx Costs, Savings
The 12th Annual Sherrill-Morgan Healthcare Conference, held September 18-19, convened employers from Ohio, Kentucky, and Tennessee to explore innovative approaches to managing escalating healthcare costs. MedBen was proud to participate, with its sales team delivering...
Sep 22, 2025 | Cost Savings, Drug costs, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings, Transparency
Across the country, more employers are moving away from traditional pharmacy benefit managers in favor of transparent solutions. MedBen Rx has been ahead of this trend for years, offering clients clarity and lower costs that others are only now beginning to seek. A...
Aug 25, 2025 | Cost Savings, Drug costs, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Rebates, Rx Costs, Transparency
A new paper from the American Medical Association (AMA) has found that the pharmacy benefit manager (PBM) marketplace remains highly concentrated, with just a few major players controlling most of the activity. Many of these PBMs are vertically integrated with health...
Jul 29, 2025 | biologics, Biosimilars, Cost Savings, MedBen Rx, Pharmacy, Pharmacy Benefits Manager (PBM), Prescription, Rx Costs, Savings
The advantages of biosimilars – clinically equivalent versions of high-price biologic drugs – have been known for years. But despite their growing availability, adoption remains slow… in no small part because major PBMs are stifling uptake....
Jul 11, 2025 | Comparative Effectiveness, Cost Savings, Drug advertising, Drug costs, Health care costs, High-value formulary, MedBen Rx, Pharmacy, Rx Costs, Spending
Pharmaceutical advertising hit a record high in 2024, with the top 10 drugs accounting for $3.3 billion in ad spending – up nearly 20% from the previous year. With more campaigns directly targeting consumers, MedBen Rx’s high-value formulary educates members about...
